Cellular Senescence Affects Cardiac Regeneration and Repair in Ischemic Heart Disease

Area of Science:

• Cardiovascular Biology
• Cellular Biology
• Regenerative Medicine

Background:

• Ischemic heart disease (IHD) involves cardiomyocyte (CM) damage, where myogenesis and angiogenesis are crucial for recovery.
• Cellular senescence, a stress-induced permanent cell cycle arrest, impairs cellular functions and promotes inflammation via the senescence-associated secretory phenotype (SASP).
• Accumulation of senescent cells (vascular endothelial cells, vascular smooth muscle cells, CMs, progenitor cells) is linked to cardiovascular diseases like myocardial infarction (MI) and ventricular remodeling.

Purpose of the Study:

• To review the processes of angiogenesis, myogenesis, and cellular senescence following IHD.
• To elucidate the relationship between cellular senescence and cardiovascular disease.
• To discuss potential therapeutic strategies targeting senescent cells for MI.

Main Methods:

• Literature review summarizing current research on IHD, cellular senescence, and cardiovascular disease.
• Analysis of the mechanisms underlying cellular senescence in the context of IHD.
• Exploration of therapeutic approaches targeting senescent cells.

Main Results:

• Cellular senescence impairs essential cardiac repair mechanisms like myogenesis and angiogenesis after IHD.
• Senescent cells and their SASP contribute to the progression of cardiovascular diseases, including MI and adverse ventricular remodeling.
• Targeting senescent cells presents a promising therapeutic avenue for managing IHD and MI.

Conclusions:

• Cellular senescence plays a significant role in the pathophysiology of IHD and its complications.
• Understanding the mechanisms of senescence in the heart is critical for developing effective treatments.
• Therapeutic strategies aimed at senescent cells hold potential for improving outcomes in patients with ischemic heart disease.